Overview
White sponge nevus (WSN), also known as Cannon's white sponge nevus, familial white folded mucosal dysplasia, or oral epithelial nevus, is a rare benign genetic disorder affecting the mucous membranes, most commonly the oral mucosa. It is caused by mutations in the keratin 4 (KRT4) or keratin 13 (KRT13) genes, which encode proteins essential for the structural integrity of mucosal epithelial cells. The condition is characterized by thick, white, spongy, folded or corrugated plaques that appear on the buccal mucosa (inner cheeks), though the tongue, floor of the mouth, and other mucosal surfaces may also be involved. In some cases, extraoral mucosal sites such as the nasal, esophageal, and anogenital mucosa can be affected. The lesions of white sponge nevus are typically present from birth or early childhood and tend to persist throughout life, though they may fluctuate in severity. The plaques are usually painless and asymptomatic, though some patients report a rough texture or mild discomfort. The condition is entirely benign and carries no risk of malignant transformation. The primary clinical significance lies in distinguishing WSN from other white oral lesions, including leukoplakia, oral candidiasis, lichen planus, and hereditary benign intraepithelial dyskeratosis, which may require different management. There is no definitive cure for white sponge nevus, and treatment is generally not required given its benign nature. For patients who experience cosmetic concerns or discomfort, topical treatments such as tetracycline mouth rinses or other antibiotic rinses have been reported to temporarily reduce the thickness and whiteness of the plaques, though lesions typically recur upon discontinuation. Genetic counseling may be offered to affected families to explain the inheritance pattern and benign prognosis of the condition.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
FDA & Trial Timeline
1 eventUniversity of Southern California — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for White sponge nevus.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for White sponge nevus at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to White sponge nevus.
Community
No community posts yet. Be the first to share your experience with White sponge nevus.
Start the conversation →Latest news about White sponge nevus
Disease timeline:
New recruiting trial: Topical Imiquimod Treatment of Oral Dysplasia
A new clinical trial is recruiting patients for White sponge nevus
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about White sponge nevus
What is White sponge nevus?
White sponge nevus (WSN), also known as Cannon's white sponge nevus, familial white folded mucosal dysplasia, or oral epithelial nevus, is a rare benign genetic disorder affecting the mucous membranes, most commonly the oral mucosa. It is caused by mutations in the keratin 4 (KRT4) or keratin 13 (KRT13) genes, which encode proteins essential for the structural integrity of mucosal epithelial cells. The condition is characterized by thick, white, spongy, folded or corrugated plaques that appear on the buccal mucosa (inner cheeks), though the tongue, floor of the mouth, and other mucosal surface
How is White sponge nevus inherited?
White sponge nevus follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does White sponge nevus typically begin?
Typical onset of White sponge nevus is childhood. Age of onset can vary across affected individuals.
Which specialists treat White sponge nevus?
15 specialists and care centers treating White sponge nevus are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.